US drugmaker Gilead Sciences has said it will donate 4.5 lakh vials of Remdesivir to the Indian government as Covid-19 cases surge in the country. The company has also said that is taking several steps to further expand the availability of the anti-viral drug in India.
India is witnessing a huge shortage of Remdesivir amid rising demand due to Covid cases. Remdesivir is approved in India for restricted emergency use fovidOVID-19 in adults and children hospitalised with severe disease.